Studies using CML models have shown that JAK2/STAT activation is directly enhanced by BCR-ABL1 kinase activity, promoting cell growth and survival [68,69]. The gene discussed is SOAT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.